ResearcherUniversity College LondonNo recent work listed

Emma C. Morris

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4834-1130; OpenAlex author ID A5002366090. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper

Papers 1

Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patients. Last author DOI 10.1158/1078-0432.ccr-17-1185 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuan Chen · 1 shared paper, 2017 · strength 0.08
- Paper Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patie… DOI 10.1158/1078-0432.ccr-17-1185 ↗
Goran Hamid Mohammad · 1 shared paper, 2017 · strength 0.08
- Paper Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patie… DOI 10.1158/1078-0432.ccr-17-1185 ↗
Stephen P. Pereira · 1 shared paper, 2017 · strength 0.08
- Paper Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patie… DOI 10.1158/1078-0432.ccr-17-1185 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.